title: Longitudinal changes in epitope recognition of autoantibodies against glutamate decarboxylase 65 (GAD65Ab) in prediabetic adults developing diabetes.
abstract: We analysed the beta cell-specific autoimmunity reflected in autoantibodies to the smaller isoform of glutamate decarboxylase (GAD65Ab) in the prediabetic period of GAD65Ab-positive healthy adults who developed Type 2 diabetes (T2D) during a follow-up period of 10 years. We found that of the adults that tested GAD65Ab-positive at baseline (n=25), six developed T2D and one developed Type 1 diabetes (T1D). Of the subjects that tested GAD65Ab-negative at baseline (n=2209), 81 developed T2D, one developed T1D and four developed unclassified diabetes, indicating that the risk for GAD65Ab-positive healthy adults to develop diabetes is increased sixfold. The GAD65Ab epitopes were characterized in a competition radioligand binding assay using recombinant Fab derived of GAD65-specific monoclonal antibodies. We observed that the GAD65Ab epitope specificities in the prediabetic period changed dynamically. Specifically, the binding to a middle and a C-terminal epitope increased during the follow-up period (P=0 x 03), causing a significant increase in the number of epitopes recognized (P=0 x 03). These findings are similar to previous observations of dynamic changes in the prediabetic period of schoolchildren at high risk for T1D development. However, the character of the epitopes differs between the two populations, suggesting differences in the beta cell-specific autoimmune response in the prediabetic period of patients with latent autoimmune diabetes in adults (LADA) and T1D.
authors.affiliation: Department of Medicine, University of Washington, Seattle, WA, USA. champe@u.washington.edu
authors.forename: C S
authors.initials: CS
authors.lastname: Hampe
authors.forename: T R
authors.initials: TR
authors.lastname: Hall
authors.forename: A
authors.initials: A
authors.lastname: Agren
authors.forename: O
authors.initials: O
authors.lastname: Rolandsson
mesh_terms: D000328:Adult; D001323:Autoantibodies / Q000097:blood*; D015551:Autoimmunity; D003922:Diabetes Mellitus, Type 1 / Q000453:epidemiology / Q000276:immunology; D003924:Diabetes Mellitus, Type 2 / Q000453:epidemiology / Q000276:immunology*; D018450:Disease Progression; D018604:Epitope Mapping; D005500:Follow-Up Studies; D005968:Glutamate Decarboxylase / Q000276:immunology* / Q000378:metabolism; D006801:Humans; D015994:Incidence; D007527:Isoenzymes / Q000276:immunology* / Q000378:metabolism; D008875:Middle Aged; D011236:Prediabetic State / Q000276:immunology*; D013548:Sweden / Q000453:epidemiology
chemical_list: D001323:Autoantibodies; D007527:Isoenzymes; D005968:Glutamate Decarboxylase; C401141:glutamate decarboxylase 2